P: Summary Resource Table [Study] Flashcards

1
Q

[lec1/2] Name the 4 components for pharmacokinetics, and an anagram for it

A

ADME: Absorption, Distribution, Metabolism, Excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

[lec1/2] Name the 4 components for pharmacodynamics, and an anagram for it

A

RICE: Receptor, Ion channel, Carrier, Enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

[lec1/2] Define the following terms:
A: Absorption
B: Distribution
C: Metabolism
D: Excretion

A

A: drug entering circulation
B: drug spreading throughout body
C: biotransformation of drug
D: removal of drug from body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

[lec1/2] Define pharmacological efficacy

A

The ability of a drug to activate a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

[lec1/2] Define clinical efficacy

A

The strength of the beneficial effect to make the patient feel better

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

[lec1/2] Define affinity. Give a formula for this

A

ability of the drug to bind. Affinity = [A]/Ka

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

[lec1/2] Define potency. Describe high vs low potency

A

How much of a drug is needed to elicit an action
High potency = only low dose needed
Low potency = higher dose needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

[lec1/2] How does the therapeutic ratio correlate to drug safety

A

The bigger the ratio, the better the drug since the range of safe dosage is large

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

[lec1/2] How can agonists differ from each other? (4)

A

can be selective or non-selective
full agonists will have spare receptors
partial agonists do not have spare receptors
full agonists desensitizes more than partial agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

[lec1/2] How do non-competitive antagonists act? (2)

A

stops and slows down system by releasing agonist in opposite direction OR
turn off enzyme that is upstream or downstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

[lec1/2] How do competitive antagonists act? (1)

A

competes with agonists for receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

[lec1/2] How can non-competitive antagonists chemically antagonise?

A

can add chemicals to bind to ligands to stop it binding to a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

[lec1/2] How can non-competitive antagonists act on the receptor? (2)

A

Allosteric modulations
Bind to receptor but not reduce affinity of agonist receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

[lec1/2] What 2 things can you do to make a competitive antagonist?

A

Decrease efficacy
Increase affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

[lec1/2] Why does low affinity make a drug dangerous?

A

Because you need a higher dosage to get the same effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

[lec3/4] Name 4 factors to consider when administering a drug

A

Convenience
Cost
Bioavailability
Local vs systemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

[lec3/4] How can you help ensure a drug stays in local circulation?

A

use a poorly absorbed drug

(also occlude your puncta if it’s a topical eye drop)

18
Q

[lec3/4] Why feature of oral administration helps drug absorption?

A

intestine has large surface area and provides maximum opportunity for absorption

(note: however, direct IV has the best absorption obviously)

19
Q

[lec3/4] What type of metabolism do drugs taken orally go through? Explain the process

A

1st-pass hepatic metabolism: drug enters hepatic portal vein and is transferred directly to the liver

20
Q

[lec3/4] Why must bioavailability be taken into account in orally administered drugs?

A

If low bioavailability, effect will be very minor since the drug will be going through 1st-pass hepatic metabolism

If low, consider alternative pathway

21
Q

[lec3/4] In regards to RAPID IV administration:
A: Describe the peak drug concentration reached in the blood
B: Describe the rate of drug elimination
C: Describe the rate of excretion

A

A: High
B: Most drugs eliminated at a rate proportional to concentration in the plasma
C: Quick excretion

22
Q

[lec3/4] In regards to SHORT-TERM IV administration:
A: Describe the peak drug concentration reached in the blood
B: What is this useful for?
C: What happens to the rate of accumulation of drug in relation to drug concentration
D: What happens to the drug when you stop infusion?

A

A: Not as high as rapid:
B: Drugs that show toxicity at high concentrations
C: rate of accumulation decreases as concentration increases
D: You get elimination only

23
Q

[lec3/4] What does drug distribution rely on? (1)

A

The binding to cells/uptake into cells

24
Q

[lec3/4] Provide the formula for volume of distribution

A

Vd = X/C

X = amount of drug in body, C = concentration of drug in blood
If C is big, need more X to get same amount distributed

25
Q

[lec3/4] How are drugs excreted? (2) Describe the processes

A

Glomerular filtration: limited by GFR; cannot remove bound protein
Tubular secretion: active carrier - can remove bound protein

(note: tubular reabsorption doesn’t count because that’s not excretion now is it)

26
Q

[lec3/4] What is lipid solubility affected by that affects drug diffusion?

A

pH

27
Q

[lec3/4] Define Phase I and II metabolism

A

Phase I: add functional group
Phase II: conjugate with water

28
Q

[lec3/4] what type of metabolism is cytochrome p450 involved in?

A

Phase I

29
Q

[lec6] Name the major sites/targets for pharmacological manipulation of synapses (8)

A
  1. conduction of action potential down axon to nerve terminal
  2. synthesis of the N.T
  3. storage of the N.T
  4. metabolism of the N.T
  5. release of the N.T
  6. uptake of the N.T
  7. degradation of the N.T
  8. Receptor for the N.T
30
Q

[lec6] Name 4 receptor families activated by N.Ts

A

ligand-gated ion channels (ionotropic receptors)
G-protein coupled receptors
Kinase-linked receptors
Nuclear receptors

31
Q

[lec6] Describe the length of the pre-ganglionic fibre vs post-ganglionic fibre for sympathetic neruons

A

pre-ganglionic = short
post-ganglionic = long

32
Q

[lec6] Describe the length of the pre-ganglionic fibre vs post-ganglionic fibre for PARASYMPATHETIC neruons

A

pre-ganglionic = long
post-ganglionic = short

33
Q

[lec6] What N.T is released by sympathetic neurons? and what receptor is there for it?

A

Noradrenaline. Alpha/beta adrenoceptors

34
Q

[lec6] What N.T is released by parasympathetic neurons? and what receptor is there for it?

A

ACh. Muscarinic receptors.

35
Q

[lec 7] How is ACh synthesized and transported? (3)

A
  1. Choline enters blood stream via choline carrier
  2. Choline + acetylCoA –> acetylcholine + CoA
  3. Acetylcholine (i.e. ACh) transported to vescile by ACh carrier
36
Q

[lec 7] How does botox affect ACh? Explain the mechanism and outcome

A

blocks the release mechanism by which the vesicle (containing ACh) fuses and releases its contents into the synapse – leads to reduced levels of ACh released in the synapse

37
Q

[lec 7] What do acetycholinesterases do? What do anticholinesterases do?

A

Breaks up ACh into acetate and choline. Therefore anticholinesterases will stop this, allowing more ACh to accumulate at the synapse

38
Q

[lec 7] Name 2 anticholinesterases and state what they are each selective for and what they each treat

A

Physostigmine: selective for parasympathetic junctions - treat glaucoma
Neostigmine: selective for NMJ - treats Myaesthenia Gravis

39
Q

[lec 7] Describe Myaesthenia Gravis and state what it leads to (3)

A

is where the nicotinic cholinergic receptors are seen as foreign. Antibodies bind them and attack them, degrading them
Leads to muscle paralysis

40
Q

[lec 7] In regards to Muscarinic Receptors:
A: What type of N.T do they respond to?
B: What are their agonist effects? (4)

A

A: cholinergic N.T
B: SLUD: salivation, lacrimation, urination, defectation (note: therefore antagonists to this receptor would have anti-slud effects)

41
Q

[lec 7] Give 2 examples of drugs that act on muscarinic receptors

A

Pilocarpine (agonist, SLUD, pupil constriction)
Atropine (antagonist, ANTI-SLUD, pupil dilation)